Literature DB >> 2843721

Expression of oncogenes in human liver disease.

Y Himeno1, Y Fukuda, M Hatanaka, H Imura.   

Abstract

To elucidate the role of oncogene expression in hepatocarcinogenesis, we examined the expression of 8 cellular oncogenes by dot blot and/or northern blot analysis in neoplastic, cirrhotic and non-cirrhotic human liver tissues obtained at surgery. Significantly higher levels of c-myc gene expression were observed in tissues of hepatocellular carcinoma (HCC) and adjacent cirrhotic tissues than in apparently normal liver tissues or those of chronic hepatitis (normal-chronic hepatitis). There was a tendency to higher c-myc mRNA levels in HCC than in liver cirrhosis. However, when tumorous and adjacent cirrhotic tissues from the same patient were compared, c-myc mRNA levels were not consistently higher in HCC. No significant differences in mRNA levels of c-fos, N-myc, N-ras, Ha-ras, c-erbA, c-erbB and c-abl were observed among the HCC, cirrhosis and normal-chronic hepatitis groups. Although the significance of increased c-myc gene expression in liver cirrhosis and HCC is still not known, it is conceivable that the persistent elevation of c-myc gene expression in cirrhosis contributes to the development of HCC.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2843721     DOI: 10.1111/j.1600-0676.1988.tb00994.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  7 in total

1.  Mycoplasmas induce transcription and production of tumor necrosis factor in a monocytic cell line, THP-1, by a protein kinase C-independent pathway.

Authors:  K Sugama; K Kuwano; M Furukawa; Y Himeno; T Satoh; S Arai
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

2.  Hypomethylation of the c-myc oncogene in liver cirrhosis and chronic hepatitis.

Authors:  N Aiba; S Nambu; K Inoue; H Sasaki
Journal:  Gastroenterol Jpn       Date:  1989-06

3.  Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma.

Authors:  T M Hagen; S Huang; J Curnutte; P Fowler; V Martinez; C M Wehr; B N Ames; F V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

4.  Comparative analysis of p53 and c-myc expression and cell proliferation in human hepatocellular carcinomas--an enhanced immunohistochemical approach.

Authors:  M Saegusa; Y Takano; H Kishimoto; G Wakabayashi; K Nohga; M Okudaira
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

5.  Molecular mechanisms underlying hepatocellular carcinoma.

Authors:  Philippe Merle; Christian Trepo
Journal:  Viruses       Date:  2009-11-09       Impact factor: 5.048

Review 6.  c-MYC-Making Liver Sick: Role of c-MYC in Hepatic Cell Function, Homeostasis and Disease.

Authors:  Kang Zheng; Francisco Javier Cubero; Yulia A Nevzorova
Journal:  Genes (Basel)       Date:  2017-04-19       Impact factor: 4.096

7.  Expression of oncogenes during rat chemical hepatotumorigenesis promoted by estrogen.

Authors:  Y Himeno; Y Fukuda; M Hatanaka; H Imura
Journal:  Jpn J Cancer Res       Date:  1989-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.